News

Psychology Today8h
Toward a Better Understanding of Electroconvulsive Therapy
When we don't understand how something works, we often fear it. That has been the case with electroconvulsive therapy (ECT), but new research may be shedding needed light.
Treating postoperative delirium as preventable 'acute brain failure': Low-cost interventions could have major impact
A new large-scale study spotlights postoperative delirium as a preventable and high-impact complication which is driven by ...
Managed Healthcare Executive1d
FDA Approves Ekterly, First Oral Treatment for Hereditary Angioedema
Ekterly comes in the form of a 300 mg tablet. The recommended dosage is 600 mg split into two doses taken at the earliest sign of an attack, according to the prescribing information. Additional ...
The American Journal of Managed Care1d
FDA Approves Sebetralstat for Hereditary Angioedema
For the second time in under 3 weeks, the FDA has approved treatment for the inherited genetic disorder characterized by ...
US FDA approves KalVista Pharma's swelling disorder drug, shares rise
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, Ekterly, for a type of ...
US FDA approves KalVista Pharma's swelling disorder drug
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading. The ...
Business Wire1d
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
Medical Mysteries: He beat a fungal infection. So why was he so ill again?
Peter Redweik’s brutal infection was quelled by a medication so powerful that doctors use it sparingly. Yet he continued to ...